Viewing StudyNCT02415413



Ignite Creation Date: 2024-05-06 @ 3:58 AM
Last Modification Date: 2024-10-26 @ 11:41 AM
Study NCT ID: NCT02415413
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-09-10
First Post: 2015-03-29

Brief Title: Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
Sponsor: PETHEMA Foundation
Organization: PETHEMA Foundation

Conditions & Keywords Data

Conditions:
Name
Smoldering Multiple Myeloma
Keywords:
Name View
Autologous stem cell transplantation View
Smoldering multiple myeloma View
Carfilzomib View
Lenalidomide View
Melphalan View
Dexamethasone View